68Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 9, 2009, Pages 1483-1494

  Liu, Zhaofei ^a,b   Niu, Gang ^a   Wang, Fan ^b   Chen, Xiaoyuan ^a  

^a STANFORD UNIVERSITY   (United States)

^b PEKING UNIVERSITY   (China)

Author keywords

Bombesin; Gallium 68 (68Ga); Gastrin releasing peptide receptor (GRPR); Integrin v 3; Peptide heterodimer; Positron emission tomography (PET); RGD peptide

Indexed keywords

1,4,7 TRIAZACYCLONOANETRIACETIC ACID ARGINYLGLYCYLASPARTIC ACID BOMBESIN GA 68; BOMBESIN; GALLIUM 68; GASTRIN RELEASING PEPTIDE RECEPTOR; INTEGRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DISTRIBUTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY;

ANIMALS; BOMBESIN; CELL LINE, TUMOR; FEMALE; GALLIUM RADIOISOTOPES; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; INTEGRIN ALPHAVBETA3; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, BOMBESIN;

EID: 68949212307     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1123-z     Document Type: Article

References (33)

1. SM Okarvi 2004 Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases Med Res Rev 24 357 397 10.1002/med.20002
2. X Chen S Liu Y Hou M Tohme R Park JR Bading, et al 2004 MicroPET imaging of breast cancer αv-integrin expression with 64Cu-labeled dimeric RGD peptides Mol Imaging Biol 6 350 359 10.1016/j.mibio.2004.06.004
3. ZB Li K Chen X Chen 2008 68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression Eur J Nucl Med Mol Imaging 35 1100 1108 10.1007/s00259-007-0692-y
4. Z Wu ZB Li W Cai L He FT Chin F Li, et al 2007 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of αvβ3 integrin expression Eur J Nucl Med Mol Imaging 34 1823 1831 10.1007/s00259-007-0427-0
5. S Liu WY Hsieh Y Jiang YS Kim SG Sreerama X Chen, et al 2007 Evaluation of a 99mTc-labeled cyclic RGD tetramer for noninvasive imaging integrin αvβ3-positive breast cancer Bioconjug Chem 18 438 446 10.1021/bc0603081
6. AJ Beer AL Grosu J Carlsen A Kolk M Sarbia I Stangier, et al 2007 [18F]galacto-RGD positron emission tomography for imaging of αvβ3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck Clin Cancer Res 13 6610 6616 10.1158/1078-0432.CCR-07-0528
7. AJ Beer R Haubner M Sarbia M Goebel S Luderschmidt AL Grosu, et al 2006 Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man Clin Cancer Res 12 3942 3949 10.1158/1078-0432.CCR-06-0266
8. R Haubner WA Weber AJ Beer E Vabuliene D Reim M Sarbia, et al 2005 Noninvasive visualization of the activated αvβ3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD PLoS Med 2 e70 10.1371/journal.pmed.0020070
9. LM Kenny RC Coombes I Oulie KB Contractor M Miller TJ Spinks, et al 2008 Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients J Nucl Med 49 879 886 10.2967/jnumed.107.049452
10. DB Cornelio R Roesler G Schwartsmann 2007 Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy Ann Oncol 18 1457 1466 10.1093/annonc/mdm058
11. A Dimitrakopoulou-Strauss P Hohenberger U Haberkorn HR Macke M Eisenhut LG Strauss 2007 68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG J Nucl Med 48 1245 1250 10.2967/jnumed.106.038091
12. C Van de Wiele P Phonteyne P Pauwels I Goethals R Van den Broecke V Cocquyt, et al 2008 Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry J Nucl Med 49 260 264 10.2967/jnumed.107. 047167
13. U Scheffel MG Pomper 2004 PET imaging of GRP receptor expression in prostate cancer J Nucl Med 45 1277 1278
14. M de Visser WM van Weerden CM de Ridder S Reneman M Melis EP Krenning, et al 2007 Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts J Nucl Med 48 88 93
15. S Liu 2006 Radiolabeled multimeric cyclic RGD peptides as integrin αvβ3 targeted radiotracers for tumor imaging Mol Pharm 3 472 87 10.1021/mp060049x
16. B Jia Z Liu J Shi Z Yu Z Yang H Zhao, et al 2008 Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer Bioconjug Chem 19 201 210 10.1021/bc7002988
17. CJ Smith WA Volkert TJ Hoffman 2005 Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes Nucl Med Biol 32 733 740 10.1016/j.nucmedbio.2005.05.005
18. ML Janssen WJ Oyen I Dijkgraaf LF Massuger C Frielink DS Edwards, et al 2002 Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model Cancer Res 62 6146 6151
19. I Dijkgraaf OC Boerman WJ Oyen FH Corstens M Gotthardt 2007 Development and application of peptide-based radiopharmaceuticals Anticancer Agents Med Chem 7 543 551
20. ZB Li W Cai Q Cao K Chen Z Wu L He, et al 2007 64Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor αvβ3 integrin expression J Nucl Med 48 1162 1171 10.2967/jnumed.107.039859
21. Y Wu X Zhang Z Xiong Z Cheng DR Fisher S Liu, et al 2005 microPET imaging of glioma integrin αvβ3 expression using 64Cu-labeled tetrameric RGD peptide J Nucl Med 46 1707 1718
22. ZB Li Z Wu K Chen EK Ryu X Chen 2008 18F-Labeled BBN-RGD heterodimer for prostate cancer imaging J Nucl Med 49 453 461 10.2967/jnumed.107.048009
23. Y Wu W Cai X Chen 2006 Near-infrared fluorescence imaging of tumor integrin αvβ3 expression with Cy7-labeled RGD multimers Mol Imaging Biol 8 226 236 10.1007/s11307-006-0041-8
24. Z Liu Y Yan FT Chin F Wang X Chen 2009 Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN J Med Chem 52 425 432 10.1021/jm801285t
25. M Fani JP Andre HR Maecke 2008 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals Contrast Media Mol Imaging 3 67 77 10.1002/cmmi.232
26. M Lacroix 2009 MDA-MB-435 cells are from melanoma, not from breast cancer Cancer Chemother Pharmacol 63 567 10.1007/s00280-008-0776-9
27. JM Rae CJ Creighton JM Meck BR Haddad MD Johnson 2007 MDA-MB-435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boon for melanoma research Breast Cancer Res Treat 104 13 19 10.1007/s10549-006-9392-8
28. W Cai X Zhang Y Wu X Chen 2006 A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido) ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of αvβ3 integrin expression J Nucl Med 47 1172 1180
29. X Zhang Z Xiong Y Wu W Cai JR Tseng SS Gambhir, et al 2006 Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2 J Nucl Med 47 113 121
30. W Cai Y Wu K Chen Q Cao DA Tice X Chen 2006 In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin αvβ3 Cancer Res 66 9673 9681 10.1158/0008-5472.CAN- 06-1480
31. X Zhang W Cai F Cao E Schreibmann Y Wu JC Wu, et al 2006 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer J Nucl Med 47 492 501
32. X Chen R Park Y Hou M Tohme AH Shahinian JR Bading, et al 2004 microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts J Nucl Med 45 1390 1397
33. A Al-Nahhas Z Win T Szyszko A Singh S Khan D Rubello 2007 What can gallium-68 PET add to receptor and molecular imaging? Eur J Nucl Med Mol Imaging 34 1897 901 10.1007/s00259-007-0568-1